Daiwa Securities Group’s Keros Therapeutics KROS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-133
Closed -$3K 1324
2025
Q4
$3K Hold
133
﹤0.01% 1277
2025
Q3
$2K Hold
133
﹤0.01% 1274
2025
Q2
$2K Hold
133
﹤0.01% 1216
2025
Q1
$1K Hold
133
﹤0.01% 1231
2024
Q4
$2K Hold
133
﹤0.01% 1218
2024
Q3
$8K Hold
133
﹤0.01% 1144
2024
Q2
$6K Hold
133
﹤0.01% 1189
2024
Q1
$9K Buy
133
+22
+20% +$1.3K ﹤0.01% 1174
2023
Q4
$4K Hold
111
﹤0.01% 1225
2023
Q3
$4K Hold
111
﹤0.01% 1174
2023
Q2
$4K Hold
111
﹤0.01% 1198
2023
Q1
$5K Hold
111
﹤0.01% 1153
2022
Q4
$5K Buy
111
+31
+39% +$1.45K ﹤0.01% 1156
2022
Q3
$3K Hold
80
﹤0.01% 1196
2022
Q2
$2K Hold
80
﹤0.01% 1244
2022
Q1
$4K Hold
80
﹤0.01% 1195
2021
Q4
$5K Hold
80
﹤0.01% 1197
2021
Q3
$3K Buy
80
+36
+82% +$1.28K ﹤0.01% 1216
2021
Q2
$2K Hold
44
﹤0.01% 1142
2021
Q1
$3K Hold
44
﹤0.01% 1109
2020
Q4
$3K Buy
+44
New +$2.77K ﹤0.01% 1087

Other funds holding KROS